266 related articles for article (PubMed ID: 32017214)
41. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
42. The Immunology of Macrophage Activation Syndrome.
Crayne CB; Albeituni S; Nichols KE; Cron RQ
Front Immunol; 2019; 10():119. PubMed ID: 30774631
[TBL] [Abstract][Full Text] [Related]
43. Macrophage Activation Syndrome.
Sen ES; Clarke SL; Ramanan AV
Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
[TBL] [Abstract][Full Text] [Related]
44. Unexpected macrophage activation syndrome in a healthy young woman: a case report.
Saviano A; Petrucci M; Tilli P; Pignataro G; Petruzziello C; Giuliano G; Ojetti V; Covino M; Franceschi F; Candelli M
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7320-7323. PubMed ID: 32706070
[TBL] [Abstract][Full Text] [Related]
45. Convergent pathways of the hyperferritinemic syndromes.
Schulert GS; Canna SW
Int Immunol; 2018 Apr; 30(5):195-203. PubMed ID: 29420734
[TBL] [Abstract][Full Text] [Related]
46. [CME: Acquired Hemophagocytic Lymphohistiocytosis].
Leinenkugel G; Buser L; Vallelian F; Herfs G
Praxis (Bern 1994); 2018 Aug; 107(16):873-881. PubMed ID: 30086677
[TBL] [Abstract][Full Text] [Related]
47. Clonal cytophagic histiocytic panniculitis in children may be cured by cyclosporine A.
Bader-Meunier B; Fraitag S; Janssen C; Brochard K; Lamant L; Wouters C; Bodemer C
Pediatrics; 2013 Aug; 132(2):e545-9. PubMed ID: 23858422
[TBL] [Abstract][Full Text] [Related]
48. [Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge].
Ruffer N; Kosch R; Weisel K; Kötter I; Krusche M
Z Rheumatol; 2024 Jun; 83(5):376-386. PubMed ID: 38267764
[TBL] [Abstract][Full Text] [Related]
49. Clinical features and correct diagnosis of macrophage activation syndrome.
Cron RQ; Davi S; Minoia F; Ravelli A
Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
[TBL] [Abstract][Full Text] [Related]
50. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
[TBL] [Abstract][Full Text] [Related]
51. The rheumatology/hematology interface: CAPS and MAS diagnosis and management.
Gansner JM; Berliner N
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):313-317. PubMed ID: 30504326
[TBL] [Abstract][Full Text] [Related]
52. Macrophage activation syndrome in malaria.
Dass R; Barman H; Duwarah SG; Choudhury V; Jain P; Deka NM; Murari M
Rheumatol Int; 2010 Jun; 30(8):1099-101. PubMed ID: 19593570
[TBL] [Abstract][Full Text] [Related]
53. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
Vastert SJ; Prakken BJ
Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
[TBL] [Abstract][Full Text] [Related]
54. Macrophage activation syndrome: advances towards understanding pathogenesis.
Grom AA; Mellins ED
Curr Opin Rheumatol; 2010 Sep; 22(5):561-6. PubMed ID: 20517154
[TBL] [Abstract][Full Text] [Related]
55. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Vandenhaute J; Wouters CH; Matthys P
Front Immunol; 2019; 10():3089. PubMed ID: 32010140
[TBL] [Abstract][Full Text] [Related]
56. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
[TBL] [Abstract][Full Text] [Related]
57. Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.
Prencipe G; Caiello I; Pascarella A; Grom AA; Bracaglia C; Chatel L; Ferlin WG; Marasco E; Strippoli R; de Min C; De Benedetti F
J Allergy Clin Immunol; 2018 Apr; 141(4):1439-1449. PubMed ID: 28807602
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis.
Ramachandran S; Zaidi F; Aggarwal A; Gera R
Blood Cells Mol Dis; 2017 May; 64():53-57. PubMed ID: 28433836
[TBL] [Abstract][Full Text] [Related]
59. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
[TBL] [Abstract][Full Text] [Related]
60. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
